Petros pharmaceuticals launches u.s. distribution of prescription ed medication stendra through recently announced collaboration with lemonaid health, a subsidiary of 23andme

Lemonaid health will offer customers more affordable access to branded ed medication stendra that may be taken as early as ~15 minutes prior to sexual activity (100mg and 200mg strengths only) [1] please see important safety information and study design below new york, ny / accesswire / may 14, 2024 / petros pharmaceuticals, inc. (nasdaq:ptpi), a company focused on expanding consumer access to medication through over-the- counter (otc) drug development programs, announces the availability of all strengths of the company's prescription erectile dysfunction (ed) medication, stendra (avanafil) on the telehealth platform lemonaid health, inc. lemonaid health is a subsidiary of 23andme holding co. (nasdaq: me), and a leading telemedicine provider. "with lemonaid's nationwide distribution and industry leading track record of treating a significant number of ed patients across the country, we are excited to collaborate with lemonaid health in this expanded access initiative for stendra.
PTPI Ratings Summary
PTPI Quant Ranking